Clinical Trials Browser

INDUSTRY × Breast Neoplasms × Lasofoxifene × Clear all

Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation